Healthcare Providers and Services
-
BSX AXNX: Boston Scientific Announces Pricing of €2 Billion Notes Offering
Boston Scientific Corp (BSX stock) announces €2 billion notes offering, financing strategic AXNX acquisition and providing investment opportunities.
-
Merck to Strengthen Cancer Drug Portfolio with Harpoon Buy
Merck's bold move to acquire Harpoon Therapeutics signals a significant shift in cancer treatment. Learn how this impacts the oncology sector.
-
Eli Lilly's Zepbound Shows Short-Lived Weight Loss Benefits
Uncover key investment insights in the dynamic obesity drug market. Discover growth, value, and momentum strategies in this evolving healthcare...
-
Beauty Health (SKIN Stock) Faces Market Turbulence, CEO Departs
Beauty Health's stock drops 64%, showing the market's reaction to its financial and operational struggles and highlighting risks and opportunities...
-
FDA Approves Eli Lilly's Weight Loss Drug Zepbound
Eli Lilly's Tirzepatide drug, already approved for treating Type 2 diabetes as Mounjaro, has received FDA approval for weight management under the...
-
Daily Stock Watch: Intuitive Surgical Climbs on Q3 Earnings Beat
Intuitive Surgical (NASDAQ: ISRG) has exceeded expectations with its latest earnings update, sending its share price higher. But is ISRG stock a...
-
Daily Stock Watch: CANO Stock Sinks on Sale Uncertainty
With the share price of Cano Health (NYSE: CANO) dropping sharply after a major player backed out of discussions to purchase the business, we ask...
-
Daily Stock Watch: VRAX Stock Climbs on Monkeypox Testing News
Virax Biolabs Group Ltd (NASDAQ: VRAX) is a heavy gainer on Tuesday morning after its new monkeypox rapid antigen test kits grabbed investors'...
-
Daily Stock Watch: Figs (NYSE: FIGS) Stock Slips
After a short-lived rally, the Figs (NYSE: FIGS) stock price dips. Is FIGS stock a good long-term investment?
-
Daily Stock Watch: Is Signify Health Stock a Buy?
Investors are snapping up shares of Signify Health (NYSE: SGFY) amid reports that the healthcare business is attracting acquisition bids from...
-
Daily Stock Watch: Is Invitae Stock Worth Buying?
Today we examine Invitae Corporation (NYSE: NVTA) stock, which has seen its price stumble on Tuesday morning. Is this testing specialist a good...
-
As Health Problems Mount Patients Welcome New Treatments
Healthcare is changing, as more and more diseases pose a growing concern for society and the companies trying to cure them.
-
Is Pfizer Stock a Buy as COVID Pills Gear Up for Approval?
Pfizer's COVID-19 pill, vaccine and CFO resignation are making headlines this week. Does the news help boost its investment thesis?
-
Investing in a Post-COVID Healthcare Revolution
The healthcare industry is vast, covering an array of disciplines, ideas and revolutionary changes. Read on to discover how investing in this...